PARTNERING
Unlock the Full Potential of Your Cell Therapy
×
Technology
Cell Shuttle™
Cartridge
Cell Q™
Software
Services
IDMO Overview
IDMO Capabilities
IDMO Advantage
IDMO Smart Factories
Partnering
Existing TAP Partners
TAP Overview
Partner With Cellares
Company
Mission
Leadership
Board of Advisors
Board of Directors
Investors
Resources
Contact
Careers
Interdisciplinary Team
Culture & Values
Perks
Opportunities
News
Partner with us
Cellares
Technology
Cell Shuttle™
Cartridge
Cell Q™
Software
Services
IDMO Overview
IDMO Capabilities
IDMO Advantage
IDMO Smart Factories
Partnering
Existing TAP Partners
TAP Overview
Partner With Cellares
Company
Mission
Leadership
Board of Advisors
Board of Directors
Investors
Resources
Contact
Careers
Interdisciplinary Team
Culture & Values
Perks
Opportunities
News
Partner with us
August 23, 2023
Exclusive: Bloomberg Technology’s Ed Ludlow Interviews Cellares’ CEO and Co-founder, Fabian Gerlinghaus on Company’s Massive $255M Series C Up-Round
Related News
April 22, 2024
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
April 18, 2024
Cellares Launches Cell Q, the World’s First Automated cGMP QC Workcell for Cell Therapies, to Resolve Manual QC Processing Bottleneck and Extend IDMO Capabilities from Manufacturing Through Quality Control
March 26, 2024
Christi Shaw, Former CEO of Kite, a Gilead Company, Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing